Please login to the form below

Not currently logged in
Email:
Password:

bNAb

This page shows the latest bNAb news and features for those working in and with pharma, biotech and healthcare.

Gilead drug reduces HIV viral reservoir, says researcher

Gilead drug reduces HIV viral reservoir, says researcher

Gilead is testing the drug in combination with other drugs including two broadly neutralising antibody (bNAbs) – PGT121 and GS-9721 – and other candidates such as an HIV vaccine candidate developed by

Latest news

  • Gilead study resurrects HIV eradication hope Gilead study resurrects HIV eradication hope

    GS-9620 is already in early-stage clinical testing, and Gilead says that it now intends to start human trials of an improved bNAb candidate - PGT121 derivative GS-9722. ... of bNAbs and a TLR7 agonist, which could have the potential to achieve long-term

  • GSK eyes £6bn from new product sales by 2020 GSK eyes £6bn from new product sales by 2020

    Company executives also highlighted GSK's anti-infectives pipeline - including long-acting integrase inhibitor cabotegravir and broadly neutralising antibodies (bnAbs) in development at its ViiV subsidiary - which are both part of

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....